Abstract

Newly emerging infections have opened up dialogue about the need for novel treatments and government response to such infections. As we continue to search for solutions, we must review the lessons learned from research and industry response in order to overcome the current challenges. There are a number of exciting new developments including traditional vaccines and application of vaccines to new diseases, such as cancer vaccines. We will also discuss innovative efficacy trials and how to accelerate vaccine development. Join us as colleagues from industry and academia gather to discuss newly licensed vaccines, new vaccine technologies, RNA-based vaccines, and adjuvant discovery.